| Year | Pharmaceuticals affecting neoplams, endocrine system, and metabolic diseases | Central nervous system and sense organ pharmaceuticals | Respiratory system pharmaceuticals | Digestive or genitourinary system pharmaceuticals |
|---|---|---|---|---|
|
2004 |
$21,694 | $23,826 | $14,851 | $15,456 |
|
2005 |
21,679 | 24,466 | 15,778 | 15,317 |
|
2006 |
21,912 | 25,906 | 17,204 | 9,887 |
|
2007 |
23,555 | 24,200 | 14,153 | 7,987 |
|
2008 |
25,224 | 20,280 | 13,327 | 7,126 |
|
2009 |
23,548 | 18,795 | 11,023 | 6,069 |
|
2010 |
20,051 | 16,880 | 11,322 | 5,370 |
|
2011 |
19,391 | 15,496 | 14,634 | 4,874 |
|
2012 |
15,945 | 12,597 | 12,514 | 4,939 |
|
2013 |
17,346 | 12,339 | 8,166 | 2,945 |
|
2014 |
15,101 | 13,123 | 8,192 | 3,214 |
|
2015 |
13,476 | 13,725 | 7,698 | 3,191 |
|
2016 |
12,365 | 13,966 | 6,548 | 2,767 |
|
Sources: U.S. Bureau of Labor Statistics and authors' calculations. |
||||